Insider Trading & Ownership - Smith Brendan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smith Brendan

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-21
Tax Withholding
2023-02-22
5:41 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
1,392$48.2616,547
(Direct)
View
2023-02-18
Exercise
2023-02-22
5:41 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
3,825$016,547
(Direct)
View
2022-10-17
Tax Withholding
2022-10-18
5:38 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
1,111$55.7613,889
(Direct)
View
2022-10-14
Exercise
2022-10-18
5:38 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
3,750$013,889
(Direct)
View
2022-10-07
Option Award
2022-10-12
5:42 pm
N/A
2032-10-07
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
14,000$014,000
(Direct)
View
2022-08-16
Option Award
2022-08-18
5:39 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
10,000$010,000
(Direct)
View
2022-02-18
Option Award
2022-02-22
5:44 pm
N/A
2032-02-18
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
45,300$045,300
(Direct)
View
2021-10-14
Option Award
2021-10-18
8:00 pm
N/A
N/A
CRISPR Therapeutics AGCRSPSmith Brendan
Chief Financial Officer
105,000$0105,000
(Direct)
View
2021-04-19
Option Award
2021-04-20
4:49 pm
N/A
2031-04-18
Translate Bio Inc.TBIOSmith Brendan
Chief Financial Officer
201,800$0201,800
(Direct)
View